VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+24.06%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$434M
AUM Growth
+$434M
(+19%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
2.78%
Top 10 Holdings %
Top 10 Hldgs %
86.36%
Holding
22
New
2
Increased
2
Reduced
–
Closed
3
Top Buys
1 |
Ascendis Pharma
ASND
|
$12.9M |
2 |
Arcturus Therapeutics
ARCT
|
$8.45M |
3 |
STML
Stemline Therapeutics, Inc.
STML
|
$1.37M |
Top Sells
1 |
RDUS
Radius Health, Inc.
RDUS
|
$9.08M |
2 |
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
|
$3.98M |
3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.37M |
Sector Composition
1 | Healthcare | 48.4% |